Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: doxorubicin, paclitaxel poliglumex, capecitabine, cyclophosphamide, methotrexate
Sponsor: University of Southern California
Collaborators: CTI BioPharma